← Back to Analyst Consensus 
HAE Buy
HAEMONETICS CORP
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 3 reiterations from 3 firms
Next Earnings
Nov 4, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 9, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 55% |
| Oct 9, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Oct 8, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Sep 17, 2026 | Citigroup | upgrade | Neutral → Buy | — | 54% |
| Sep 3, 2026 | Raymond James | maintain | Outperform → Outperform | — | 53% |
| Aug 21, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Aug 19, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 55% |
| Aug 18, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Aug 7, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Aug 6, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 15, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jun 26, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 17, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 15, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 28, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| May 22, 2026 | B of A Securities | upgrade | Neutral → Buy | — | 53% |
| May 12, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 55% |
| May 8, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Apr 13, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Apr 7, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Mar 11, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Feb 6, 2026 | Citigroup | maintain | Neutral → Neutral | $75 | 54% |
| Feb 6, 2026 | Mizuho | maintain | Outperform → Outperform | $80 | 52% |
| Feb 6, 2026 | Barrington Research | maintain | Outperform → Outperform | $94 | 55% |
| Feb 6, 2026 | BTIG | reiterate | Buy → Buy | $88 | 52% |
| Feb 2, 2026 | Barrington Research | maintain | Outperform → Outperform | $93 | 55% |
| Jan 12, 2026 | Barrington Research | maintain | Outperform → Outperform | $93 | 55% |
| Jan 9, 2026 | BTIG | reiterate | Buy → Buy | $88 | 52% |
| Dec 17, 2025 | Mizuho | maintain | Outperform → Outperform | $90 | 52% |
| Dec 15, 2025 | Baird | maintain | Outperform → Outperform | $99 | 55% |
| Dec 15, 2025 | Needham | downgrade | Buy → Hold | $0 | 50% |
| Dec 12, 2025 | JP Morgan | maintain | Neutral → Neutral | $74 | 55% |
| Dec 11, 2025 | Citigroup | downgrade | Buy → Neutral | $88 | 54% |
| Nov 21, 2025 | BTIG | reiterate | Buy → Buy | $88 | 52% |
| Nov 7, 2025 | Barrington Research | maintain | Outperform → Outperform | $90 | 55% |
| Nov 7, 2025 | Needham | maintain | Buy → Buy | $78 | 50% |
| Nov 6, 2025 | BTIG | maintain | Buy → Buy | $88 | 52% |
| Oct 21, 2025 | Barrington Research | maintain | Outperform → Outperform | $86 | 55% |
| Oct 7, 2025 | Citigroup | maintain | Buy → Buy | $64 | 54% |
| Sep 23, 2025 | Barrington Research | maintain | Outperform → Outperform | $86 | 55% |
| Aug 11, 2025 | Raymond James | downgrade | Strong Buy → Outperform | $78 | 53% |
| Aug 8, 2025 | Barrington Research | maintain | Outperform → Outperform | $86 | 55% |
| Aug 8, 2025 | Mizuho | maintain | Outperform → Outperform | $70 | 52% |
| Aug 8, 2025 | JP Morgan | downgrade | Overweight → Neutral | $62 | 55% |
| Aug 7, 2025 | Needham | maintain | Buy → Buy | $68 | 50% |
| Jul 11, 2025 | Barrington Research | maintain | Outperform → Outperform | $95 | 55% |
| Jul 9, 2025 | Citigroup | upgrade | Neutral → Buy | $90 | 54% |
| Jun 26, 2025 | Baird | initiate | — → Outperform | $87 | 55% |
| May 20, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $100 | 53% |
Price Target Trend
Jun 5, 2026 Oct 27, 2026
EPS Estimates
+1y —
0y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days